02096 SIMCERE PHARMA
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.00X | Oper Margin | 13.4% |
|---|---|---|---|
| LT Debt/Equity | 1.3% | Net Margin | 11.1% |
| Total Debt/Equity | 17.1% | Return on Equity | 10.4% |
| Price/Book | 4.75X | Return on Assets | 6.4% |
| (HKD 14.130) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 779.72 | 787.81 | 1,043.69 | 1,843.33 | 794.60 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -1.0 | -24.5 | -43.4 | +132.0 | -29.2 |
| Earnings Per Share (HKD) | 0.31 | 0.302 | 0.4 | 0.707 | 0.332 |
| Earnings Per Share Growth (%) | +2.8 | -24.4 | -43.4 | +112.8 | +100.0 |
| Dividend Per Share (HKD) | 0.175 | 0.176 | 0.176 | 0.176 | 0.180 |
| P/E* (X) | 45.54 | 46.79 | 35.35 | 20.00 | 42.55 |
| Yield (%) | 1.24 | 1.24 | 1.24 | 1.24 | 1.28 |
| Dividend Share (%) | 56.33 | 58.18 | 43.98 | 24.87 | 54.29 |
| Book NAV (HKD) | 2.975 | 3.026 | 3.006 | 2.996 | 2.412 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-09-08 21:40:20
Latest Result
| (RMBMn) | 2025-06 | 2024-06 | Chg* (%) | 2023-06 |
| Cover Period (mths) | 6 | 6 | NA | 6 |
|---|---|---|---|---|
| Turnover | 3,585 | 3,114 | +15.1 | 3,382 |
| Operating Result | 662.917 | 496.479 | +33.5 | 1,534 |
| Associates | -0.173 | 0.591 | -129.3 | 0.393 |
| Profit Before Taxation | 662.485 | 494.693 | +33.9 | 2,324 |
| Taxation | 58.878 | 38.093 | +54.6 | 51.346 |
| Profit /( Loss) After Taxation | 603.607 | 456.6 | +32.2 | 2,273 |
| Minority Interests | 0 | 0 | N/A | -0.811 |
| Net Profit | 603.607 | 456.6 | +32.2 | 2,274 |
| Earnings Per Share () | 0.2706 | 0.1923 | +40.7 | 0.9369 |
| Announcement Date | 2025-08-21 | 2024-08-21 | NA | 2023-08-21 |
* Annualised
Last Update Time: 2025-09-08 21:40:25
